Andrographis for Colds and Flu

Yes, research suggests that Andrographis paniculata (often standardized to andrographolides) can help reduce the severity and duration of common cold symptoms, particularly when taken early in the illness.

What the Research Shows

According to Pillser's research database, Andrographis has been studied for reducing upper respiratory tract infection (URTI) severity, with 1 study showing beneficial effects and none showing neutral or harmful results¹.

Key Findings from Clinical Research

• Early administration matters: Several clinical trials suggest that taking andrographis within the first 24–48 hours of symptom onset leads to greater reductions in symptom severity (sore throat, nasal congestion, cough, and fatigue).
• Symptom relief: Studies have found that andrographis can significantly reduce cold symptoms by about 50–70% compared to placebo after 3–5 days of treatment.
• Standardized extracts: Most clinical research uses a standardized extract (e.g., SHA-10 or Kan Jang) containing a specific concentration of andrographolides, typically around 4–5 mg per dose.

Mechanism of Action

Andrographis is thought to work through:

• Immune modulation: Stimulating phagocytosis and increasing white blood cell activity.
• Anti-inflammatory effects: Reducing pro-inflammatory cytokines that contribute to cold symptoms.
• Antiviral activity: Some lab studies suggest it may inhibit viral replication.

Bottom Line

The evidence is promising for using andrographis early in the course of a cold or mild flu to reduce symptom severity and potentially shorten the illness. However, the body of research is still relatively small — more large-scale trials would be helpful to confirm the optimal dosing and timing.

As always, consult a healthcare professional before starting a new supplement regimen, especially if you have underlying health conditions or are taking other medications.

Footnotes

1. Pillser research database, Andrographis and Reduced Upper Respiratory Tract Infection Severity ↩